BackDermapharm Holding SE Overview

Dermapharm Holding SE Accounts Payable

Latest accounts payable for DMPHF: $100M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$100.33M
↑ 6.71% YoYΔ $6.31M vs prior year quarter

Peer trimmed avg / median

Loading

Dermapharm Holding SE Accounts Payable History

Loading

Dermapharm Holding SE vs. peers: Accounts Payable Comparison

Loading

Dermapharm Holding SE Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Dermapharm Holding SE (DMPHF) FAQ

As of the most recent data (September 2026), DMPHF shows a accounts payable of $100M. That compares with $94M in the prior-year period — up 6.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, DMPHF's accounts payable is now $100M (was $94M) — a 6.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Dermapharm Holding SE is outperforming or lagging.

Tracking DMPHF's accounts payable over time shows whether Dermapharm Holding SE is scaling, shrinking, or reshaping that part of the business. The current reading is $100M That compares with $94M in the prior-year period — up 6.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Dermapharm Holding SE's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $100M) with ownership activity and broader fundamentals.